177Lu-PNT2002 (177Lu-PSMA radiopharmaceutical)

Lutetium-177 labeled PSMA-targeted radiopharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-PNT2002 (177Lu-PSMA radiopharmaceutical), covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma [Phase 2]